Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT)

被引:0
作者
Rox, JM [1 ]
Reinartz, J [1 ]
Kramer, MD [1 ]
机构
[1] UNIV HEIDELBERG,IMMUNOPATHOL LAB,INST IMMUNOL,D-69120 HEIDELBERG,GERMANY
关键词
interleukin-1; beta; tissue-type plasminogen activator; inflammation;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Human keratinocytes synthesize and secrete tissue-type plasminogen activator (tPA). tPA converts the inactive precursor enzyme plasminogen into the trypsinlike proteinase plasmin, tPA is not found in normal epidermis, but in lesional epidermis from patients with a variety of cutaneous diseases, including psoriasis, pemphigus and pemphigoid, The presence of tPA is probably a reaction to the disease process rather than the initiating event in these etiologically and histopathologically diverse lesions, However, the factor(s) that upregulate tPA expression and secretion in keratinocytes have remained largely elusive, We sought to determine whether the inflammatory cytokine interleukin-1 beta (IL-1 beta), which is commonly present in diverse epidermal lesions, influences tPA production, Accordingly, we studied the influence of IL-1 beta on secretion of tPA by cells of the human keratinocyte cell line HaCaT, We found that IL-1 beta increased tPA secretion in these cells, Given the observation that IL-1 beta is a common proinflammatory mediator in cutaneous diseases, our findings may explain the increase in tPA in clinically and etiologically diverse inflammatory epidermal lesions.
引用
收藏
页码:554 / 558
页数:5
相关论文
共 36 条
[1]   MESSENGER-RNA FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS PRESENT IN LESIONAL EPIDERMIS FROM PATIENTS WITH PSORIASIS, PEMPHIGUS, OR BULLOUS PEMPHIGOID, BUT IS NOT DETECTED IN NORMAL EPIDERMIS [J].
BAIRD, J ;
LAZARUS, GS ;
BELIN, D ;
VASSALLI, JD ;
BUSSO, N ;
GUBLER, P ;
JENSEN, PJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (05) :548-552
[2]   KERATINOCYTES AS INITIATORS OF INFLAMMATION [J].
BARKER, JNWN ;
MITRA, RS ;
GRIFFITHS, CEM ;
DIXIT, VM ;
NICKOLOFF, BJ .
LANCET, 1991, 337 (8735) :211-214
[3]  
BLACK RA, 1988, J BIOL CHEM, V263, P9437
[4]   TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[5]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[6]   ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR PLASMINOGEN ACTIVATORS [J].
BUESSECKER, F ;
REINARTZ, J ;
SCHIRMER, U ;
KRAMER, MD .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 162 (02) :193-200
[7]  
Buessecker F, 1995, Exp Dermatol, V4, P357, DOI 10.1111/j.1600-0625.1995.tb00060.x
[8]   PLASMINOGEN BINDING-SITES IN NORMAL HUMAN SKIN [J].
BURGE, SM ;
MARSHALL, JM ;
CEDERHOLMWILLIAMS, SA .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (01) :35-41
[9]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[10]  
DANO K, 1989, ADV CANCER RES, P1